Yu L - Search Results

1

A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis.

Huang Y, Haraguchi M, Lawrence DA, Border WA, Yu L, Noble NA. Huang Y, et al. Among authors: yu l. J Clin Invest. 2003 Aug;112(3):379-88. doi: 10.1172/JCI18038. J Clin Invest. 2003. PMID: 12897205 Free PMC article.

2

Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms.

Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens RT, Yu L, Noble NA, Border W. Huang Y, et al. Among authors: yu l. Kidney Int. 2006 Jan;69(1):105-13. doi: 10.1038/sj.ki.5000011. Kidney Int. 2006. PMID: 16374430 Free article.

3

TGF-beta isoforms in renal fibrogenesis.

Yu L, Border WA, Huang Y, Noble NA. Yu L, et al. Kidney Int. 2003 Sep;64(3):844-56. doi: 10.1046/j.1523-1755.2003.00162.x. Kidney Int. 2003. PMID: 12911534 Free article.

4

Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect.

Yu L, Border WA, Anderson I, McCourt M, Huang Y, Noble NA. Yu L, et al. Kidney Int. 2004 Nov;66(5):1774-84. doi: 10.1111/j.1523-1755.2004.00901.x. Kidney Int. 2004. PMID: 15496148 Free article.

5

A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy.

Huang Y, Border WA, Yu L, Zhang J, Lawrence DA, Noble NA. Huang Y, et al. Among authors: yu l. J Am Soc Nephrol. 2008 Feb;19(2):329-38. doi: 10.1681/ASN.2007040510. Epub 2008 Jan 23. J Am Soc Nephrol. 2008. PMID: 18216319 Free PMC article.

6

Therapeutic strategies to halt renal fibrosis.

Yu L, Noble NA, Border WA. Yu L, et al. Curr Opin Pharmacol. 2002 Apr;2(2):177-81. doi: 10.1016/s1471-4892(02)00144-3. Curr Opin Pharmacol. 2002. PMID: 11950630 Review.

7

Inhibition of integrin α2β1 ameliorates glomerular injury.

Borza CM, Su Y, Chen X, Yu L, Mont S, Chetyrkin S, Voziyan P, Hudson BG, Billings PC, Jo H, Bennett JS, Degrado WF, Eckes B, Zent R, Pozzi A. Borza CM, et al. Among authors: yu l. J Am Soc Nephrol. 2012 Jun;23(6):1027-38. doi: 10.1681/ASN.2011040367. Epub 2012 Mar 22. J Am Soc Nephrol. 2012. PMID: 22440900 Free PMC article.

8

Integrin α1/Akita double-knockout mice on a Balb/c background develop advanced features of human diabetic nephropathy.

Yu L, Su Y, Paueksakon P, Cheng H, Chen X, Wang H, Harris RC, Zent R, Pozzi A. Yu L, et al. Kidney Int. 2012 Jun;81(11):1086-97. doi: 10.1038/ki.2011.474. Epub 2012 Feb 1. Kidney Int. 2012. PMID: 22297672 Free PMC article.

9

Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesis.

Borza CM, Su Y, Tran TL, Yu L, Steyns N, Temple KJ, Skwark MJ, Meiler J, Lindsley CW, Hicks BR, Leitinger B, Zent R, Pozzi A. Borza CM, et al. Among authors: yu l. Matrix Biol. 2017 Jan;57-58:258-271. doi: 10.1016/j.matbio.2016.11.009. Epub 2016 Dec 1. Matrix Biol. 2017. PMID: 27915093 Free PMC article.

10

The high efficacy of claudin18.2-targeted CAR-T cell therapy in advanced pancreatic cancer with a strategy to ensure the safety of patients.

Zhong G, Zhang X, Zhao R, Guo Z, Wang C, Yu C, Liu D, Hu K, Gao Y, Zhao B, Liu X, Shi X, Chen L, Li Y, Yu L. Zhong G, et al. Among authors: yu l. Mol Ther. 2025 Jan 9:S1525-0016(25)00016-4. doi: 10.1016/j.ymthe.2025.01.012. Online ahead of print. Mol Ther. 2025. PMID: 39797399

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,199 results

Search Page

Filters